GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » Cyclically Adjusted Revenue per Share

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Cyclically Adjusted Revenue per Share : $11.20 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted revenue per share for the three months ended in Mar. 2024 was $2.346. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $11.20 for the trailing ten years ended in Mar. 2024.

During the past 12 months, PT Kalbe Farma Tbk's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PT Kalbe Farma Tbk was 7.30% per year. The lowest was 6.30% per year. And the median was 6.80% per year.

As of today (2024-05-23), PT Kalbe Farma Tbk's current stock price is $17.03. PT Kalbe Farma Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $11.20. PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio of today is 1.52.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Kalbe Farma Tbk was 4.48. The lowest was 2.23. And the median was 3.36.


PT Kalbe Farma Tbk Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Cyclically Adjusted Revenue per Share Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.19 6.62 6.56 6.46 10.07

PT Kalbe Farma Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.40 7.70 9.09 10.07 11.20

Competitive Comparison of PT Kalbe Farma Tbk's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio falls into.



PT Kalbe Farma Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kalbe Farma Tbk's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.346/130.6070*130.6070
=2.346

Current CPI (Mar. 2024) = 130.6070.

PT Kalbe Farma Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.538 93.015 2.160
201409 1.530 94.576 2.113
201412 1.581 98.819 2.090
201503 1.385 98.388 1.839
201506 1.432 99.766 1.875
201509 1.283 101.037 1.658
201512 1.472 102.133 1.882
201603 1.462 102.764 1.858
201606 1.621 103.212 2.051
201609 1.582 104.142 1.984
201612 1.587 105.222 1.970
201703 1.569 106.476 1.925
201706 1.656 107.722 2.008
201709 1.589 108.020 1.921
201712 1.604 109.017 1.922
201803 1.555 110.097 1.845
201806 1.589 111.085 1.868
201809 1.514 111.135 1.779
201812 1.590 112.430 1.847
201903 1.607 112.829 1.860
201906 1.754 114.730 1.997
201909 1.700 114.905 1.932
201912 1.782 115.486 2.015
202003 1.511 116.252 1.698
202006 1.733 116.630 1.941
202009 1.571 116.397 1.763
202012 1.820 117.318 2.026
202103 1.761 117.840 1.952
202106 1.871 118.184 2.068
202109 2.007 118.262 2.217
202112 2.142 119.516 2.341
202203 2.090 120.948 2.257
202206 1.986 123.322 2.103
202209 2.070 125.298 2.158
202212 2.119 126.098 2.195
202303 2.246 126.953 2.311
202306 2.092 127.663 2.140
202309 2.044 128.151 2.083
202312 2.212 129.395 2.233
202403 2.346 130.607 2.346

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PT Kalbe Farma Tbk  (OTCPK:PTKFY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PT Kalbe Farma Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.03/11.2
=1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Kalbe Farma Tbk was 4.48. The lowest was 2.23. And the median was 3.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PT Kalbe Farma Tbk Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Industry
Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines